Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Income towards Parent Company: 2016-2025

Historic Income towards Parent Company for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $31.5 million.

  • Collegium Pharmaceutical's Income towards Parent Company rose 237.51% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.4 million, marking a year-over-year decrease of 34.03%. This contributed to the annual value of $42.4 million for FY2024, which is 7.88% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Income towards Parent Company stood at $31.5 million for Q3 2025, which was up 162.93% from $12.0 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Income towards Parent Company's 5-year high stood at $72.8 million during Q2 2021, with a 5-year trough of -$25.0 million in Q4 2021.
  • In the last 3 years, Collegium Pharmaceutical's Income towards Parent Company had a median value of $13.0 million in 2023 and averaged $14.8 million.
  • The largest annual percentage gain for Collegium Pharmaceutical's Income towards Parent Company in the last 5 years was 7,577.45% (2021), contrasted with its biggest fall of 459.79% (2021).
  • Collegium Pharmaceutical's Income towards Parent Company (Quarterly) stood at -$25.0 million in 2021, then soared by 71.24% to -$7.2 million in 2022, then skyrocketed by 543.67% to $31.9 million in 2023, then plummeted by 60.75% to $12.5 million in 2024, then skyrocketed by 237.51% to $31.5 million in 2025.
  • Its Income towards Parent Company was $31.5 million in Q3 2025, compared to $12.0 million in Q2 2025 and $2.4 million in Q1 2025.